FTC Staff Provides Comments to FDA on Naming Proposal for Biologic Products
Date
The staff of the Federal Trade Commission has submitted a comment to the U.S. Food and Drug Administration in response to the FDA’s request for comment on its draft guidance addressing nonproprietary...